WNK2 and melanoma: Castro-Perez and collaborators (2019) reported that melanoma-derived iPC cells exhibit an increased mitogen-activated protein kinase (MAPK) inhibitor resistance, suggesting that cellular reprogramming of cancer cells can serve as a model to understand melanoma cell plasticity-dependent mechanisms especially in the recurrence of aggressive drug-resistant melanoma [63].